Drug incompatibilities in intravenous therapy: evaluation and proposition of preventive tools in intensive care and hematology units.
Ophélie MaisonCléa TardyDelphine CabelguenneStéphanie ParatSophie DucastelleVincent PiriouAlain LepapeLaure LalandePublished in: European journal of clinical pharmacology (2018)
Given the frequency and the potential for severe consequences of PCI, pharmacists have a role to play in raising awareness of nurses and practitioners, and proposing adequate tools and solutions to reduce their incidence.
Keyphrases
- primary care
- general practice
- coronary artery disease
- risk factors
- healthcare
- percutaneous coronary intervention
- acute myocardial infarction
- acute coronary syndrome
- mental health
- high dose
- early onset
- drug induced
- atrial fibrillation
- st elevation myocardial infarction
- human health
- risk assessment
- bone marrow
- coronary artery bypass grafting
- adverse drug
- climate change
- replacement therapy
- electronic health record